Systemic Lupus Erythematosus
Henry Ford Health System – Rheumatology Primary Coordinator: Jenna Hudy 313-916-9328 Indication: Systemic Lupus Erythematosus Enrollment Status: Coming soon Protocol: GSK219240 Drug: Belimumab Sponsor: GlaxoSmithKline Description: A phase 4, multicenter, prospective, open-label study describing the […]
Vasculitis
Henry Ford Health System – Rheumatology Primary Coordinator: Jenna Hudy 313-916-9328 Indication: Vasculitis Enrollment Status: Open Protocol: 20220159 Drug: Avacopan Sponsor: Amgen Description: A randomized, double-blind, placebo-controlled phase 4 clinical trial to evaluate the […]
Sjogren’s Syndrome
Clinical Research Institute of Michigan – Shores Rheumatology Primary Coordinator: Amelia Paliewicz 586-598-3329 X 201 Indication: Sjogren’s Syndrome Enrollment Status: Open Protocol: HZNP-DAZ-301, HZNP-DAZ-301 HZNP-DAZ-304 “Oasis” Drug: Dazodalibep Sponsor: Horizon/Amgen […]